Quantifying the feasibility of shortening clinical trial duration using surrogate markers (Q95375)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Quantifying the feasibility of shortening clinical trial duration using surrogate markers |
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Quantifying the feasibility of shortening clinical trial duration using surrogate markers |
scientific article |
Statements
40
0 references
28
0 references
6321-6343
0 references
2 September 2021
0 references
